证券代码：688329 证券简称：艾隆科技 公告编号：2025-055 苏州艾隆科技股份有限公司 关于召开 2025 年第三季度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 会议召开时间：2025 年 12 月 04 日（星期四）13:00-14:00 会议召开地点：上海证券交易所上证路演中心（网址： https://roadshow.sseinfo.com/） （一）会议召开时间：2025 年 12 月 04 日（星期四）13:00-14:00 会议召开方式：上证路演中心网络互动 投资者可于 2025 年 11 月 27 日（星期四）至 12 月 03 日（星期 三）16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或 通过苏州艾 隆科技股份有限公司（ 以下简称"公司"）邮箱 8103@iron-tech.cn 进行提问。公司将在说明会上对投资者普遍关注 的问题进行回答。 公司已于 2025 年 10 月 28 日发布公司 2025 年第三季度报告，为 便于广大投资者更全面深入地 ...

Core Insights - The stock of Elon Technology (688329) closed at 22.00 yuan on November 24, 2025, with a rise of 3.14% and a trading volume of 15,600 hands, resulting in a transaction amount of 34.0164 million yuan [1] Fund Flow Analysis - On November 24, 2025, the net outflow of main funds was 379,600 yuan, accounting for 1.12% of the total transaction amount, while retail investors had a net inflow of 216,770 yuan, representing 6.37% of the total transaction amount [1][2] - Over the past five days, the stock experienced fluctuations in fund flows, with notable net inflows and outflows from different investor categories [2] Company Financial Performance - For the first three quarters of 2025, Elon Technology reported a main revenue of 280 million yuan, an increase of 25.12% year-on-year, while the net profit attributable to shareholders was -959,000 yuan, up 96.56% year-on-year [3] - The third quarter of 2025 saw a single-quarter main revenue of 149 million yuan, reflecting an 83.53% year-on-year increase, and a net profit attributable to shareholders of 7.4313 million yuan, up 182.09% year-on-year [3] - The company has a total market value of 1.698 billion yuan, with a net asset of 792 million yuan and a debt ratio of 42.74% [3] Industry Comparison - Elon Technology's financial metrics show a market value significantly lower than the industry average of 7.393 billion yuan, with a net profit margin of -0.92% compared to the industry average of 4.37% [3] - The company's gross profit margin stands at 45.79%, which is higher than the industry average of 27.79%, indicating strong operational efficiency in its sector [3]

Core Viewpoint - On November 21, Ailong Technology experienced a decline of 4.95% with a trading volume of 48.73 million yuan, indicating a potential market reaction to recent financial performance and investor sentiment [1] Financing Summary - On the same day, Ailong Technology had a financing purchase amount of 7.44 million yuan and a financing repayment of 2.52 million yuan, resulting in a net financing purchase of 4.91 million yuan [1] - As of November 21, the total financing and securities lending balance for Ailong Technology was 57.79 million yuan, which accounts for 3.51% of its market capitalization, indicating a low financing balance compared to the 20th percentile over the past year [1] - There were no shares repaid or sold in the securities lending market on November 21, with a total securities lending balance of 0.00 yuan, suggesting a high level of inactivity in this area compared to the 90th percentile over the past year [1] Company Overview - Ailong Technology, established on January 20, 2006, and listed on March 29, 2021, focuses on intelligent management of medical supplies, providing comprehensive solutions through smart management devices and software platforms for healthcare institutions [2] - The company's revenue composition includes: smart emergency pharmacy products (43.34%), maintenance services (16.55%), inpatient and infusion center products (16.03%), and other categories [2] - As of September 30, the number of shareholders was 5,144, a decrease of 4.99%, while the average circulating shares per person increased by 5.25% to 15,007 shares [2] Financial Performance - For the period from January to September 2025, Ailong Technology reported a revenue of 280 million yuan, reflecting a year-on-year growth of 25.12%, while the net profit attributable to the parent company was -0.96 million yuan, showing a significant year-on-year improvement of 96.56% [2] Dividend Information - Since its A-share listing, Ailong Technology has distributed a total of 111 million yuan in dividends, with 49.05 million yuan distributed over the past three years [3] Institutional Holdings - As of September 30, 2025, the sixth largest circulating shareholder of Ailong Technology was the Dacheng CSI 360 Internet + Index A (002236), holding 741,700 shares, which is a decrease of 86,500 shares compared to the previous period [3]

Core Insights - The stock of Elon Technology (688329) closed at 21.33 yuan on November 21, 2025, down 4.95% with a trading volume of 22,400 hands and a transaction amount of 48.73 million yuan [1] Financial Performance - For the first three quarters of 2025, Elon Technology reported a main revenue of 280 million yuan, an increase of 25.12% year-on-year [3] - The net profit attributable to shareholders was -959,000 yuan, an increase of 96.56% year-on-year [3] - The third quarter alone saw a main revenue of 149 million yuan, up 83.53% year-on-year, and a net profit of 7.43 million yuan, up 182.09% year-on-year [3] - The company’s gross margin stood at 45.79%, significantly higher than the industry average of 27.79% [3] Market Position - Elon Technology's total market capitalization is 1.647 billion yuan, which is below the industry average of 7.276 billion yuan, ranking 261 out of 270 in the specialized equipment industry [3] - The company has a price-to-earnings ratio of -1287.96, indicating a negative earnings situation compared to the industry average of 129.66 [3] - The company's return on equity (ROE) is -0.13%, ranking 220 out of 270 in the industry [3] Capital Flow Analysis - On November 21, 2025, the net inflow of main funds was 1.0361 million yuan, accounting for 2.13% of the total transaction amount [2] - Retail investors showed a net outflow of 2.2222 million yuan, representing 4.56% of the total transaction amount [2] - Over the past five days, the stock has experienced fluctuations in capital flow, with notable net outflows from retail investors on multiple days [2]

Group 1 - The core point of the news is that Ailong Technology's stock price has dropped by 5.04%, currently trading at 21.31 CNY per share, with a total market capitalization of 1.645 billion CNY [1] - Ailong Technology, established on January 20, 2006, focuses on intelligent management of medical supplies, providing comprehensive solutions through smart management devices and software platforms for healthcare institutions [1] - The company's main revenue sources include smart emergency pharmacy products (43.34%), maintenance services (16.55%), inpatient and infusion center products (16.03%), and other categories [1] Group 2 - Among Ailong Technology's top circulating shareholders, Dacheng Fund's index fund has reduced its holdings by 86,500 shares, now holding 741,700 shares, which is 0.96% of the circulating shares [2] - The Dacheng Zhongzheng 360 Internet + Index A fund has achieved a year-to-date return of 38.22% and a one-year return of 39.52%, ranking 871 out of 4208 and 577 out of 3972 respectively [2]

Market Overview - The medical consumables supply chain SPD sector experienced a decline of 1.42% on November 19, with Ailong Technology leading the drop [1] - The Shanghai Composite Index closed at 3946.74, up 0.18%, while the Shenzhen Component Index closed at 13080.09, unchanged [1] Stock Performance - Key stocks in the medical consumables supply chain SPD sector showed mixed performance, with Jianfa Zhixin rising by 3.19% to a closing price of 34.00, while several others, including Guoyao Yici and Jiuzhoutong, saw declines of 0.55% and 0.59% respectively [1] - The trading volume and turnover for Jianfa Zhixin were 180,800 hands and 620 million yuan, respectively [1] Capital Flow - The medical consumables supply chain SPD sector saw a net outflow of 99.05 million yuan from main funds, while retail investors contributed a net inflow of 74.72 million yuan [2] - Notable individual stock capital flows included Jianfa Zhixin with a net inflow of 70.39 million yuan from main funds, while Ailong Technology experienced a net outflow of 2.99 million yuan [3]

Market Overview - The medical consumables supply chain SPD sector experienced a decline of 1.51% on November 17, with the leading stock, Kaikai Industrial, falling significantly [1] - The Shanghai Composite Index closed at 3972.03, down 0.46%, while the Shenzhen Component Index closed at 13202.0, down 0.11% [1] Stock Performance - Notable gainers in the SPD sector included: - Langma Information: closed at 14.57, up 1.75% with a trading volume of 69,100 shares and a turnover of 100 million yuan - Dashi Intelligent: closed at 3.04, up 1.00% with a trading volume of 527,100 shares and a turnover of 160 million yuan - Guoxin Health: closed at 10.05, up 0.60% with a trading volume of 103,900 shares and a turnover of 104 million yuan [1] - Major decliners included: - Kaikai Industrial: closed at 14.83, down 4.14% with a trading volume of 312,500 shares and a turnover of 463 million yuan - Jianfa Zhixin: closed at 34.76, down 3.44% with a trading volume of 137,400 shares and a turnover of 481 million yuan - Yingte Group: closed at 11.85, down 2.79% with a trading volume of 87,300 shares and a turnover of 104 million yuan [2] Capital Flow - The SPD sector saw a net outflow of 244 million yuan from institutional investors, while retail investors contributed a net inflow of 241 million yuan [2] - The detailed capital flow for selected stocks showed: - Guokai Hengtai: net inflow of 7.31 million yuan from institutional investors - Dashi Intelligent: net outflow of 8.11 million yuan from retail investors - Langma Information: net outflow of 1.80 million yuan from retail investors [3]

Group 1 - The second extraordinary general meeting of shareholders for Suzhou Ailong Technology Co., Ltd. was held on November 14, 2025, at the company's headquarters [2][3] - The meeting was legally convened and presided over by a director due to the absence of the chairman [3][4] - All resolutions presented at the meeting were approved without any objections [2][5] Group 2 - The meeting included the approval of significant resolutions, such as the cancellation of the supervisory board and amendments to the company's articles of association [5][6] - The company also approved the renewal of the auditing firm for the fiscal year 2025 [6] - A lawyer from Beijing Guantao Law Firm witnessed the meeting, confirming that all procedures complied with relevant laws and regulations [6]

证券代码：688329 证券简称：艾隆科技 公告编号：2025-054 苏州艾隆科技股份有限公司 2025年第二次临时股东大会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次会议是否有被否决议案：无 一、 会议召开和出席情况 （一） 股东大会召开的时间：2025 年 11 月 14 日 （二） 股东大会召开的地点：苏州市工业园区新庆路 71 号艾隆科技一楼会议室 （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： | 1、出席会议的股东和代理人人数 | 23 | | --- | --- | | 普通股股东人数 | 23 | | 2、出席会议的股东所持有的表决权数量 | 31,144,265 | | 普通股股东所持有表决权数量 | 31,144,265 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比 | 41.8077 | | 例（%） | | | 普通股股东所持有表决权数量占公司表决权数量的比例（%） | 41.8077 | 注：上述 ...

北京观韬律师事务所 法律意见书 Tel：86 10 66578066 Fax：86 10 66578016 E-mail：guantao@guantao.com http：// www.guantao.com 中国北京市西城区金融大街 5 号 新盛大厦 B 座 19 层 邮编：100033 19/F, Tower B, Xin Sheng Plaza, No.5, Finance Street, Beijing ,100033 北京观韬律师事务所 关于苏州艾隆科技股份有限公司 2025年第二次临时股东大会的法律意见书 观意字2025BJ002858号 致：苏州艾隆科技股份有限公司 北京观韬律师事务所 法律意见书 在本法律意见书中，本所律师仅对本次股东大会会议召集和召开的程序是否 符合法律、行政法规、《规则》和《公司章程》的规定、出席本次会议现场会议 人员的资格、会议表决程序、会议表决结果是否合法有效发表意见，并不对本次 会议所审议议案的内容以及该等议案所表述的事实或数据的真实性和准确性发 表意见。本所律师假定公司提交给本所律师的资料（包括但不限于有关人员的居 民身份证、股票账户卡、授权委托书、营业执照、网络投 ...